Abstract
First generation drug-eluting stents (DES) have significantly improved the treatment options for patients with symptomatic coronary artery disease by decreasing rates of acute vessel closure and restenosis after percutaneous coronary revascularization procedures. However, early enthusiasm was temperd by reports of late stent thrombosis (LST), which raised concerns about safety. Since millions of DES have been implanted in patients worldwide, it is imperative to understand the pathology of DES in man. Autopsy studies from the CVPath DES registry documented that delayed arterial healing is accompanied by poor endothelialization of stent struts which is the single best predictor of late stent thrombosis. Arterial healing of DES is highly heterogeneous and is dependent on underlying plaque morphology as well as on the stent location. We identified several anatomical and pathological changes in man, which were associated with LST; these include hypersensitivity reaction to polymer, plaque rupture, bifurcation sites, malapposition and stent fracture. DES was also associated with premature atherosclerotic changes versus BMS.
Keywords: Stent thrombosis, pathology, DES, delayed healing, bifurcation, malapposition, hypersensitivity, myocardial infarction, atherosclerotic change, Drug-Eluting Stent, coronary artery disease, restenosis, late stent thrombosis, Autopsy, plaque rupture, polymer-based sirolimus, paclitaxel, drug-eluting stents, Academic Research Consortium, lymphocytes, polyethylene-covinyl acetate, bare-metal ST, Cypher, optical coherence tomography, lipoproteins, V-Stenting, T-Stenting, Crush-Stenting, Culotte- Stenting, left obtuse marginal (LOM) artery, macrophages
Current Pharmaceutical Design
Title: Pathobiology of Stent Thrombosis after Drug-Eluting Stent Implantation
Volume: 16 Issue: 36
Author(s): Marc Vorpahl, Saami K. Yazdani, Masataka Nakano, Elena Ladich, Frank D. Kolodgie, Aloke V. Finn and Renu Virmani
Affiliation:
Keywords: Stent thrombosis, pathology, DES, delayed healing, bifurcation, malapposition, hypersensitivity, myocardial infarction, atherosclerotic change, Drug-Eluting Stent, coronary artery disease, restenosis, late stent thrombosis, Autopsy, plaque rupture, polymer-based sirolimus, paclitaxel, drug-eluting stents, Academic Research Consortium, lymphocytes, polyethylene-covinyl acetate, bare-metal ST, Cypher, optical coherence tomography, lipoproteins, V-Stenting, T-Stenting, Crush-Stenting, Culotte- Stenting, left obtuse marginal (LOM) artery, macrophages
Abstract: First generation drug-eluting stents (DES) have significantly improved the treatment options for patients with symptomatic coronary artery disease by decreasing rates of acute vessel closure and restenosis after percutaneous coronary revascularization procedures. However, early enthusiasm was temperd by reports of late stent thrombosis (LST), which raised concerns about safety. Since millions of DES have been implanted in patients worldwide, it is imperative to understand the pathology of DES in man. Autopsy studies from the CVPath DES registry documented that delayed arterial healing is accompanied by poor endothelialization of stent struts which is the single best predictor of late stent thrombosis. Arterial healing of DES is highly heterogeneous and is dependent on underlying plaque morphology as well as on the stent location. We identified several anatomical and pathological changes in man, which were associated with LST; these include hypersensitivity reaction to polymer, plaque rupture, bifurcation sites, malapposition and stent fracture. DES was also associated with premature atherosclerotic changes versus BMS.
Export Options
About this article
Cite this article as:
Vorpahl Marc, K. Yazdani Saami, Nakano Masataka, Ladich Elena, D. Kolodgie Frank, V. Finn Aloke and Virmani Renu, Pathobiology of Stent Thrombosis after Drug-Eluting Stent Implantation, Current Pharmaceutical Design 2010; 16 (36) . https://dx.doi.org/10.2174/138161210794454879
DOI https://dx.doi.org/10.2174/138161210794454879 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitric Oxide is a Central Common Metabolite in Vascular Dysfunction Associated with Diseases of Human Pregnancy
Current Vascular Pharmacology Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
Current Drug Safety Granulomatosis with Polyangiitis (GPA) in a 15-year-old Girl with Facial Acne-like Ulcers: A Case Report
Infectious Disorders - Drug Targets Perivascular Inflammation and Hypertensive Cardiovascular Remodeling
Current Hypertension Reviews Catatonia Due to a General Medical Condition (Organic Catatonia)
Current Psychiatry Reviews Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence
Cardiovascular & Hematological Agents in Medicinal Chemistry Antithrombotic Therapy in Cardiac Embolism
Current Cardiology Reviews Refractory Behçet’s Disease with Multi-organ Involvement - Learning from Failure
Current Rheumatology Reviews Recent Progress of Machine Learning in Gene Therapy
Current Gene Therapy Rheumatologic Aspects of the COVID-19 Pandemic: A Practical Resource for Physicians in Kuwait and the Gulf region as Recommended by the Kuwait Association of Rheumatology
Current Rheumatology Reviews Aging and immunopathology in primary Sjögren's syndrome
Current Aging Science The Promotional Effect of Mesenchymal Stem Cell Homing on Bone Tissue Regeneration
Current Stem Cell Research & Therapy Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Current Signal Transduction Therapy Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem
Current Drug Targets Overview of Hyperuricaemia and Gout
Current Pharmaceutical Design Experimental Approaches Towards Allergic Asthma Therapy-Murine Asthma Models
Recent Patents on Inflammation & Allergy Drug Discovery Colchicine: An Old Wine in a New Bottle?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Molecular Mechanisms of Diabetic Nephropathy and Its Therapeutic Intervention
Current Drug Targets Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review
Current Drug Metabolism Allergic and Pseudoallergic Reactions Induced by Glucocorticoids: A Review
Current Pharmaceutical Design